Hypoxia Inducible Factor-1α and Vascular Endothelial Growth Factor Expression are Associated with a Poor Prognosis in Patients with Nasopharyngeal Carcinoma Receiving Radiotherapy with Carbogen and Nicotinamide
Abstract
Aims
Hypoxia reduces tumour radiosensitivity and hypoxia inducible factor-1α (HIF-1α) plays an important role in this process. The aim of the study was to assess the prognostic impact of HIF-1α and vascular endothelial growth factor (VEGF) in patients with nasopharyngeal carcinoma who received radiation with hypoxia-modifying therapy (carbogen plus nicotinamide).
Materials and methods
The immunohistochemical expression of HIF-1α and VEGF was evaluated in nasopharyngeal carcinoma biopsies from 59 patients who received conventional radiotherapy combined with carbogen and nicotinamide.
Results
A significant positive association was found between HIF-1α and VEGF expression (P
=
0.003). There was no association found between the level of HIF-1α, VEGF expression and tumour stage, nodal stage, or clinical stage. Kaplan–Meier plots showed that positive HIF-1α and VEGF expression were associated with a higher distant metastasis, a worse overall and disease-free survival, and the level of HIF-1α and VEGF expression had no effect on locoregional recurrence. The multivariate analysis failed to confirm any association between HIF-1α or VEGF and metastasis, disease-free or overall survival.
Conclusions
These results suggest that the expression of hypoxia-associated markers (HIF-1α and VEGF) may have prognostic significance in patients with nasopharyngeal carcinoma who receive radiation plus carbogen and nicotinamide, but further study is needed.
Key words: Hypoxia inducible factor-1α, nasopharyngeal carcinoma, prognosis, radiotherapy, vascular endothelial growth factor
To access this article, please choose from the options below
PII: S0936-6555(08)00286-0
doi:10.1016/j.clon.2008.07.001
© 2008 The Royal College of Radiologists. Published by Elsevier Inc. All rights reserved.
